Literature DB >> 20616768

Healing and healing rates of chronic wounds in the age of molecular pathogen diagnostics.

R D Wolcott1, S B Cox, S E Dowd.   

Abstract

OBJECTIVE: To compare healing outcomes at a wound healing centre both before and after the introduction of molecular pathogen diagnostics.
METHOD: An IT consultant was recruited to analyse the medical records of patients at a wound healing centre, comparing patient groups from 2007 and 2009 - before and after the introduction of comprehensive molecular pathogen diagnostic methods.
RESULTS: Before the implementation of molecular diagnostics, 244/503 patients (48.5%) healed completely, while after implementation 298/479 patients (62.4%) healed. Furthermore, based on survival analysis and after controlling for potential confounding factors, time to healing was significantly shorter in 2009 than 2007 (p<0.05). Specifically, biofilm-based wound care, along with the implementation of comprehensive molecular diagnostics for venous leg ulcers, pressure ulcers and diabetic foot ulcers and all wounds combined showed, respectively, 21%, 23%, 25% and 22% reductions in the time to healing. In addition, after implementing molecular diagnostics, the use of expensive fi rst-line antibiotics also declined in 2009, while a broader range of targeted antibiotics was used.
CONCLUSION: The results of modern molecular pathogen diagnostic applications allow comprehensive evaluation of the microbial bioburden in chronic wounds. This comprehensive diagnostic in turn has led to a more precise and targeted therapeutic approach to wound care. With the comprehensive nature of molecular diagnostics future advances in topical patient specific therapeutics are now possible.

Entities:  

Mesh:

Year:  2010        PMID: 20616768

Source DB:  PubMed          Journal:  J Wound Care        ISSN: 0969-0700            Impact factor:   2.072


  23 in total

1.  Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model.

Authors:  Stephanie DeLeon; Allie Clinton; Haley Fowler; Jake Everett; Alexander R Horswill; Kendra P Rumbaugh
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 2.  Diagnostic and Prognostic Utility of Non-Invasive Multimodal Imaging in Chronic Wound Monitoring: a Systematic Review.

Authors:  Rashmi Mukherjee; Suman Tewary; Aurobinda Routray
Journal:  J Med Syst       Date:  2017-02-13       Impact factor: 4.460

3.  Clinically Addressing Biofilm in Chronic Wounds.

Authors:  Christopher Attinger; Randy Wolcott
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-06       Impact factor: 4.730

Review 4.  Wound Healing Finally Enters the Age of Molecular Diagnostic Medicine.

Authors:  Owatha L Tatum; Scot E Dowd
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-06       Impact factor: 4.730

Review 5.  Treatment Options to Manage Wound Biofilm.

Authors:  Curtis E Jones; John P Kennedy
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-06       Impact factor: 4.730

6.  Evaluation of the bacterial diversity of pressure ulcers using bTEFAP pyrosequencing.

Authors:  Drake M Smith; David E Snow; Eric Rees; Ann M Zischkau; J Delton Hanson; Randall D Wolcott; Yan Sun; Jennifer White; Shashi Kumar; Scot E Dowd
Journal:  BMC Med Genomics       Date:  2010-09-21       Impact factor: 3.063

7.  Ulcerative dermatitis in C57BL/6 mice lacking stearoyl CoA desaturase 1.

Authors:  Lisa Krugner-Higby; Richard Brown; Matthew Rassette; Melissa Behr; Ogi Okwumabua; Mark Cook; Cynthia Bell; Matthew T Flowers; James Ntambi; Annette Gendron
Journal:  Comp Med       Date:  2012-08       Impact factor: 0.982

8.  Efficacy of a new multifunctional surfactant-based biomaterial dressing with 1% silver sulphadiazine in chronic wounds.

Authors:  Christoph Zölß; Jürgen D Cech
Journal:  Int Wound J       Date:  2014-09-08       Impact factor: 3.315

9.  Clinical identification of bacteria in human chronic wound infections: culturing vs. 16S ribosomal DNA sequencing.

Authors:  Daniel D Rhoads; Stephen B Cox; Eric J Rees; Yan Sun; Randall D Wolcott
Journal:  BMC Infect Dis       Date:  2012-11-24       Impact factor: 3.090

10.  The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds.

Authors:  Allen J Duplantier; Monique L van Hoek
Journal:  Front Immunol       Date:  2013-07-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.